Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma.
作者信息
Mailhot Vega Raymond B, Castellino Sharon M, Pei Qinglin, Parsons Susan, Roberts Kenneth B, Hodgson David, Charpentier Anne-Marie, Fitzgerald Thomas J, Kessel Sandy K, Keller Frank G, Kelly Kara, Hoppe Bradford S
机构信息
Department of Radiation Oncology, University of Florida, Jacksonville, FL, USA.
Department of Pediatrics, Emory University/Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA USA.
出版信息
Int J Part Ther. 2021 Oct 28;8(3):55-57. doi: 10.14338/IJPT-21-00012.1. eCollection 2022 Winter.
Abstract
摘要
相似文献
1
Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma.评估当代儿童肿瘤学组针对晚期霍奇金淋巴瘤开展的AHOD1331试验中质子放射治疗使用情况的差异。
Int J Part Ther. 2021 Oct 28;8(3):55-57. doi: 10.14338/IJPT-21-00012.1. eCollection 2022 Winter.
2
Proton Therapy for Pediatric Hodgkin Lymphoma.儿童霍奇金淋巴瘤的质子治疗
Pediatr Blood Cancer. 2016 Sep;63(9):1522-6. doi: 10.1002/pbc.26044. Epub 2016 May 3.
3
A Comparative Evaluation of Normal Tissue Doses for Patients Receiving Radiation Therapy for Hodgkin Lymphoma on the Childhood Cancer Survivor Study and Recent Children's Oncology Group Trials.儿童癌症幸存者研究及近期儿童肿瘤学组试验中接受霍奇金淋巴瘤放射治疗患者的正常组织剂量比较评估。
Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):707-11. doi: 10.1016/j.ijrobp.2016.01.053. Epub 2016 Feb 4.
4
Pediatric classical Hodgkin lymphoma.小儿经典型霍奇金淋巴瘤。
Pediatr Blood Cancer. 2021 May;68 Suppl 2:e28562. doi: 10.1002/pbc.28562.
5
Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology Group.儿童肿瘤协作组关于适应性治疗和挽救策略在局限期经典型霍奇金淋巴瘤中应用的 AHOD0431 试验结果
Cancer. 2018 Aug 1;124(15):3210-3219. doi: 10.1002/cncr.31519. Epub 2018 May 8.
6
Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database.美国晚期经典型霍奇金淋巴瘤的当代结果：监测、流行病学和最终结果数据库分析。
Oncologist. 2019 Nov;24(11):1488-1495. doi: 10.1634/theoncologist.2019-0172. Epub 2019 Aug 29.
7
Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 Trial.化疗敏感型儿童霍奇金淋巴瘤适应性放疗反应的预测因素分析：儿童肿瘤协作组AHOD 0031试验分析
Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):943-950. doi: 10.1016/j.ijrobp.2016.07.015.
8
Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma.接受调强放射治疗的霍奇金淋巴瘤和非霍奇金淋巴瘤患者放射性肺炎的预测因素
Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):175-82. doi: 10.1016/j.ijrobp.2015.02.010.
9
Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?放射治疗在晚期霍奇金淋巴瘤或非霍奇金淋巴瘤中起作用吗？
Curr Treat Options Oncol. 2016 Jan;17(1):4. doi: 10.1007/s11864-015-0377-x.
10
Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology Group.儿童霍奇金国际预后评分（CHIPS）预测霍奇金淋巴瘤的无事件生存：来自儿童肿瘤学组的报告。
Pediatr Blood Cancer. 2017 Apr;64(4). doi: 10.1002/pbc.26278. Epub 2016 Oct 27.
引用本文的文献
1
Comparison of Contemporary Radiation Therapy Approaches in Combined Modality Treatment on Pediatric High-Risk Classic Hodgkin Lymphoma Study: AHOD 1331.小儿高危经典型霍奇金淋巴瘤联合治疗中当代放射治疗方法的比较研究：AHOD 1331
Int J Radiat Oncol Biol Phys. 2025 Jun 28. doi: 10.1016/j.ijrobp.2025.06.3876.
2
Racial and Ethnic Demographic Reporting in Phase 2 Proton Therapy Clinical Trials: A Review.质子治疗二期临床试验中的种族和族裔人口统计学报告：综述
Int J Part Ther. 2023 May 15;10(1):51-58. doi: 10.14338/IJPT-22-00042.1. eCollection 2023 Summer.
3
Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma.儿童肿瘤学组 2023 年研究蓝图：霍奇金淋巴瘤。
Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30580. doi: 10.1002/pbc.30580. Epub 2023 Jul 28.
4
Children's Oncology Group's 2023 blueprint for research: Radiation oncology.儿童肿瘤学组 2023 年研究蓝图：放射肿瘤学。
Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30593. doi: 10.1002/pbc.30593. Epub 2023 Jul 24.
5
Radiation Therapy Use in Refractory and Relapsed Adolescent and Young Adult Hodgkin Lymphoma: A Report from the Children's Oncology Group.难治性和复发性青少年及年轻成人霍奇金淋巴瘤的放射治疗应用：来自儿童肿瘤学组的报告。
Int J Radiat Oncol Biol Phys. 2023 Oct 1;117(2):400-403. doi: 10.1016/j.ijrobp.2023.04.022. Epub 2023 Apr 26.
本文引用的文献
1
Race Disparities in Proton Radiotherapy Use for Cancer Treatment in Patients Enrolled in Children's Oncology Group Trials.参加儿童肿瘤学组试验的癌症患者在质子放疗用于癌症治疗方面的种族差异。
JAMA Oncol. 2020 Sep 1;6(9):1465-1468. doi: 10.1001/jamaoncol.2020.2259.
2
Cancer Disparities and Health Equity: A Policy Statement From the American Society of Clinical Oncology.癌症差异与健康公平：美国临床肿瘤学会政策声明。
J Clin Oncol. 2020 Oct 10;38(29):3439-3448. doi: 10.1200/JCO.20.00642. Epub 2020 Aug 12.
3
A positive approach: advances in proton therapy for the treatment of mediastinal lymphoma.
Expert Rev Hematol. 2020 Mar;13(3):197-200. doi: 10.1080/17474086.2020.1713745. Epub 2020 Feb 24.
4
Pediatric hodgkin lymphoma: disparities in survival by race.儿童霍奇金淋巴瘤：种族差异导致的生存率差异。
Leuk Lymphoma. 2020 Mar;61(3):546-556. doi: 10.1080/10428194.2019.1680841. Epub 2019 Oct 23.
5
Survival by Race and Ethnicity in Pediatric and Adolescent Patients With Hodgkin Lymphoma: A Children's Oncology Group Study.儿童和青少年霍奇金淋巴瘤患者的种族和民族存活率：儿童肿瘤学组研究。
J Clin Oncol. 2019 Nov 10;37(32):3009-3017. doi: 10.1200/JCO.19.00812. Epub 2019 Sep 20.
6
Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee.来自粒子治疗协作组（PTCOG）淋巴瘤小组委员会的关于质子治疗在淋巴瘤中应用的循证综述。
Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):825-842. doi: 10.1016/j.ijrobp.2017.05.004. Epub 2017 Sep 21.
Zotero 插件